Ferrous Sulfate
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | FOLVRON | — | 1946-08-13 | fda.gov ↗ |
Trials 60 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 104 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT05349630 Comparator | Mar 2028 → Dec 2029 expected | — | University of Colorado, Denver | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT02005588 Comparator | Dec 2013 → Jun 2015 | iron deficiency anemia | Cairo University | Completed | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT00535561 Comparator | Jun → Sep 2007 | hypothyroidism, iron deficiency anemia | Duzce University | Completed | No outcome recorded |
| Phase 1 | NCT00867867 Comparator | Oct 2003 → Jun 2008 | Helicobacter pylori infectious disease | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT03484845 Comparator | Nov 2018 → Dec 2019 | iron deficiency anemia | Assiut University | Unknown | No outcome recorded |
| Phase 1/2 | NCT07110935 Comparator | Sep 2018 → Feb 2019 | — | Federal Teaching Hospital Abakaliki | Completed | No outcome recorded |
| Phase 28 trials | ||||||
| Phase 2 | NCT05299411 Comparator | Apr 2023 → Mar 2025 | chemotherapy-induced toxicity, colon carcinoma | Korea University Guro Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT05340465 Comparator | Nov 2022 → Jan 2027 expected | disorder of iron metabolism and transport, iron deficiency anemia | University of Washington | Recruiting | No outcome recorded |
| Phase 2 | NCT03891277 Comparator | Apr 2019 → Oct 2021 | cerebral infarction, cognitive impairment with or without cerebellar ataxia, iron deficiency anemia, transient ischemic attack +1 | Beijing Tiantan Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT03759353 Comparator | Jan → Oct 2018 | iron deficiency anemia | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT03232554 Comparator | Jun 2017 → Dec 2018 | iron deficiency anemia | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT02499354 Comparator | Aug 2014 → Sep 2021 | iron deficiency anemia, restless legs syndrome | Auerbach Hematology Oncology Associates P C | Completed | No outcome recorded |
| Phase 2 | NCT01670955 Comparator | Dec 2012 → Jun 2013 | anemia | Lagos State University | Completed | No outcome recorded |
| Phase 2 | NCT01438372 Comparator | Nov 2011 → Feb 2012 | inflammatory bowel disease, iron deficiency anemia | Wayne State University | Withdrawn | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT03940430 Comparator | Sep → Nov 2018 | iron deficiency anemia | yasmin gamal el gendy | Completed | No outcome recorded |
| Phase 2/3 | NCT00929409 Comparator | Jun 2009 → Jul 2010 | iron deficiency anemia, postpartum depression, puerperal disorder | Norwegian University of Science and Technology | Terminated | No outcome recorded |
| Phase 333 trials | ||||||
| Phase 3 | NCT07556731 Comparator | May 2026 → May 2027 expected | iron deficiency anemia, iron metabolism disease | Hospital General de Mexico | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07381426 Comparator | Feb → Dec 2026 expected | anemia | Dhaka Medical College | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06884280 Comparator | Nov 2025 → Oct 2027 expected | iron deficiency anemia | Hull University Teaching Hospitals NHS Trust | Recruiting | No outcome recorded |
| Phase 3 | NCT06366698 Comparator | Nov 2023 → Dec 2025 | iron deficiency anemia | Arrowhead Regional Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT05784870 Comparator | Feb 2023 → Dec 2024 | aregenerative anemia | Zhongnan Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT05462704 Comparator | Jan 2023 → Mar 2027 expected | iron deficiency anemia, pregnancy disorder | Women and Infants Hospital of Rhode Island | Recruiting | No outcome recorded |
| Phase 3 | NCT05304442 Comparator | Sep 2022 → Mar 2025 overdue | iron deficiency anemia, uterine disorder | Baylor College of Medicine | Recruiting | No outcome recorded |
| Phase 3 | NCT05126901 Comparator | Nov 2021 → Jun 2024 | iron deficiency anemia | Shield Therapeutics | Completed | No outcome recorded |
| Phase 3 | NCT04976179 Comparator | Aug 2021 → Apr 2023 | iron deficiency anemia | University of Lagos, Nigeria | Completed | No outcome recorded |
| Phase 3 | NCT04253626 Comparator | Jan 2021 → Jul 2024 | iron deficiency anemia, pregnancy disorder | Stanford University | Completed | No outcome recorded |
| Phase 3 | NCT03957057 Comparator | Sep 2020 → Apr 2022 | deficiency anemia, iron deficiency anemia | University Medical Centre Ljubljana | Completed | No outcome recorded |
| Phase 3 | NCT04087993 Comparator | May → Dec 2020 | iron deficiency anemia | Dr. Frank Behrens | Withdrawn | No outcome recorded |
| Phase 3 | NCT05225545 Comparator | Nov 2019 → May 2024 | iron deficiency anemia, ulcerative colitis | American University of Beirut Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT03523117 Comparator | Jan 2019 → Dec 2020 | iron deficiency anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03817957 Comparator | Sep 2018 → Dec 2023 | iron deficiency anemia | Prof. Dr. Frank Behrens | Completed | No outcome recorded |
| Phase 3 | NCT03212781 Comparator | Jun → Sep 2016 | anemia | Assiut University | Completed | No outcome recorded |
| Phase 3 | NCT03378791 Comparator | Dec 2015 → Oct 2017 | iron deficiency anemia | Hatem AbuHashim | Completed | No outcome recorded |
| Phase 3 | NCT02541708 Comparator | Sep 2015 → Apr 2018 | iron deficiency anemia | Ifakara Health Institute | Unknown | No outcome recorded |
| Phase 3 | NCT03106454 Comparator | Aug 2014 → Jan 2024 | anovulation | University of Southern California | Completed | No outcome recorded |
| Phase 3 | NCT01656434 Comparator | Nov 2012 → Feb 2014 | — | Organon and Co | Terminated | No outcome recorded |
| Phase 3 | NCT01155375 Comparator | Oct 2011 → Jun 2014 | iron deficiency anemia | AMAG Pharmaceuticals, Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT01155388 Comparator | Oct 2011 → Jun 2014 | chronic kidney disease, iron deficiency anemia | AMAG Pharmaceuticals, Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT01425463 Comparator | Mar 2011 → Oct 2013 | iron deficiency anemia | Sanol GmbH | Completed | No outcome recorded |
| Phase 3 | NCT01131624 Comparator | May 2010 → May 2014 | anemia | Vifor Pharma | Completed | No outcome recorded |
| Phase 3 | NCT00994318 Comparator | Dec 2009 → Feb 2013 | chronic kidney disease, iron deficiency anemia | Vifor Pharma | Completed | No outcome recorded |
| Phase 3 | NCT00982007 Comparator | Sep 2009 → Mar 2011 | iron deficiency anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00704353 Comparator | Jun 2008 → Jul 2009 | anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00354484 Comparator | May → Dec 2006 | — | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00317239 Comparator | May 2005 → Feb 2007 | anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00395993 Comparator | May 2005 → Apr 2006 | anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00396292 Comparator | Feb → Nov 2005 | anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00236977 Comparator | Aug 2003 → Oct 2004 | anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00236964 Comparator | Feb 2001 → May 2002 | anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 443 trials | ||||||
| Phase 4 | NCT07659184 Comparator | Oct 2026 → Sep 2028 expected | anemia | University of Aarhus | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07414199 Comparator | Jan → Jun 2026 overdue | iron deficiency anemia | Children's Hospital of Orange County | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07605676 Background | Jan → Aug 2026 overdue | iron deficiency anemia | Cairo University | Recruiting | No outcome recorded |
| Phase 4 | NCT05060731 Comparator | Sep 2025 → Dec 2027 expected | anemia | University of Pecs | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07053475 Comparator | Apr 2025 → Mar 2026 | diastolic heart failure, disorder of iron metabolism and transport, iron deficiency anemia, systolic heart failure | Syed Hamza Mufarrih | Terminated | No outcome recorded |
| Phase 4 | NCT06830941 Comparator | Feb 2025 → Feb 2027 expected | anemia | Xie Jingyuan, MD | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06176430 Comparator | Feb → Mar 2024 | cerebral palsy, iron deficiency anemia | Shaheed Zulfiqar Ali Bhutto Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT05714007 Comparator | Aug 2023 → Dec 2025 overdue | anemia | Peking Union Medical College Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT05691257 Background | Feb → Aug 2023 | anemia, chronic kidney disease, heart failure | China-Japan Friendship Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT05708170 Comparator | Jan 2023 → Aug 2026 overdue | iron deficiency anemia | Liverpool Hope University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05114278 Background | Jul 2022 | celiac disease | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
| Phase 4 | NCT05047211 Comparator | Oct 2021 → Mar 2023 | iron deficiency anemia | The University of Texas Medical Branch, Galveston | Completed | No outcome recorded |
| Phase 4 | NCT04278651 Comparator | Sep 2021 → Aug 2026 overdue | iron deficiency anemia, pregnancy disorder | Thomas Jefferson University | Recruiting | No outcome recorded |
| Phase 4 | NCT04608539 Comparator | May 2021 → Jun 2023 | aregenerative anemia | Michael Kremke | Completed | No outcome recorded |
| Phase 4 | NCT04610827 Comparator | Nov 2020 → Jun 2021 | iron metabolism disease, periodic limb movement disorder, restless legs syndrome | Mayo Clinic | Terminated | No outcome recorded |
| Phase 4 | NCT04205266 Comparator | Feb 2020 → Jan 2025 | iron deficiency anemia | Thomas Jefferson University | Unknown | No outcome recorded |
| Phase 4 | NCT03830034 Comparator | Feb → Oct 2019 | iron deficiency anemia | Ain Shams University | Unknown | No outcome recorded |
| Phase 4 | NCT04435574 Comparator | Sep 2018 → Apr 2019 | iron deficiency anemia | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT03524651 Comparator | May 2018 → Jan 2021 | iron deficiency anemia | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Completed | No outcome recorded |
| Phase 4 | NCT03438227 Comparator | Apr 2018 → Dec 2019 | disorder of mineral absorption and transport, iron deficiency anemia | Indiana University | Completed | No outcome recorded |
| Phase 4 | NCT04267653 Comparator | Jan 2018 | iron deficiency anemia | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT03295851 Comparator | Nov 2017 → Mar 2019 | anemia | Singapore General Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03229954 Comparator | Aug 2017 → Apr 2019 | postgastrectomy syndrome | Yonsei University | Unknown | No outcome recorded |
| Phase 4 | NCT03188445 Comparator | Jul 2017 → Jun 2020 | iron deficiency anemia | Pharmacosmos A/S | Completed | No outcome recorded |
| Phase 4 | NCT03010579 Comparator | Oct 2016 → Dec 2017 | anemia, lymphoma | Peking University | Unknown | No outcome recorded |
| Phase 4 | NCT02631668 Comparator | Jan 2016 → Dec 2018 | iron deficiency anemia | Huashan Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02825719 Background | Dec 2015 → Mar 2020 | leiomyoma | Queen Mary Hospital, Hong Kong | Terminated | No outcome recorded |
| Phase 4 | NCT03202615 Comparator | Sep 2015 → Aug 2018 | microcytic anemia | Abdelwahed, Mai Mahmoud Mohamed, M.D. | Unknown | No outcome recorded |
| Phase 4 | NCT01975272 Comparator | Mar 2015 → May 2018 | — | Maastricht University Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT02271997 Comparator | Dec 2014 → Jun 2017 | disorder of iron metabolism and transport | Rijnstate Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02243735 Comparator | Nov 2014 → Nov 2019 | anemia, colorectal carcinoma | Academic Medical Center - University of Amsterdam | Unknown | No outcome recorded |
| Phase 4 | NCT02228902 Comparator | Aug 2014 → May 2015 | disorder of mineral absorption and transport | Rijnstate Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02086968 Comparator | Jan 2014 → Jul 2016 | iron deficiency anemia | American Regent, Inc. | Completed | No outcome recorded |
| Phase 4 | NCT01904864 Comparator | Jul 2013 → Nov 2015 | iron deficiency anemia | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT01701310 Comparator | Apr 2012 → Dec 2014 | anemia, colorectal carcinoma | Nottingham University Hospitals NHS Trust | Completed | No outcome recorded |
| Phase 4 | NCT02620345 Background | Jan 2010 → Oct 2015 | benign neoplasm of corpus uteri | Trieu, Nguyen Thi, M.D. | Completed | No outcome recorded |
| Phase 4 | NCT00689793 Comparator | Nov 2008 → Oct 2010 | disorder of iron metabolism and transport | University of Lausanne | Completed | No outcome recorded |
| Phase 4 | NCT00746551 Comparator | Sep 2008 → Mar 2010 | anemia, pregnancy disorder | Mahidol University | Completed | No outcome recorded |
| Phase 4 | NCT00830037 Comparator | Aug 2008 → Nov 2014 | chronic kidney disease, iron deficiency anemia | Indiana University | Terminated | No outcome recorded |
| Phase 4 | NCT01078818 Comparator | May 2007 → May 2009 | anemia | Fundación Canaria Rafael Clavijo para la Investigación Biomédica | Completed | No outcome recorded |
| Phase 4 | NCT00223938 Comparator | Dec 2003 → Apr 2007 | anemia | Sanofi | Terminated | No outcome recorded |
| Phase 4 | NCT00224042 Comparator | Apr 2003 → May 2005 | chronic renal failure syndrome, iron deficiency anemia | Watson Pharmaceuticals | Completed | No outcome recorded |
| Phase 4 | NCT00224055 Comparator | Apr 2003 → Sep 2004 | chronic renal failure syndrome, iron deficiency anemia | Watson Pharmaceuticals | Completed | No outcome recorded |
| Phase not applicable12 trials | ||||||
| — | NCT07366502 Comparator | Sep 2025 → Jul 2026 overdue | disorder of iron metabolism and transport, iron deficiency anemia | Medeni Şermet | Recruiting | No outcome recorded |
| — | NCT06742528 Comparator | Jan → Dec 2024 overdue | iron deficiency anemia | Arooj Khan | Recruiting | No outcome recorded |
| — | NCT05581420 Comparator | Jun 2022 → May 2025 | inflammatory bowel disease | Leiden University Medical Center | Unknown | No outcome recorded |
| — | NCT05309499 Comparator | Dec 2021 → Sep 2025 | iron deficiency anemia, myocardial infarction | Kazan State Medical University | Completed | No outcome recorded |
| — | NCT03777514 Comparator | Aug 2019 → Oct 2021 | post-surgical hypoinsulinemia | Johns Hopkins University | Withdrawn | No outcome recorded |
| — | NCT02888171 Comparator | Sep 2016 → Feb 2019 | anemia, chronic kidney disease, disorder of iron metabolism and transport | University of Alabama at Birmingham | Completed | No outcome recorded |
| — | NCT02558725 Comparator | Apr 2015 → Feb 2016 | pregnancy disorder | Assuta Hospital Systems | Unknown | No outcome recorded |
| — | NCT01628770 Comparator | May → Dec 2012 | — | Dow University of Health Sciences | Completed | No outcome recorded |
| — | NCT01590134 Comparator | Mar → Dec 2012 | — | Imperial College London | Unknown | No outcome recorded |
| — | NCT01755455 Comparator | Jun 2011 → Nov 2012 | cystic fibrosis, iron deficiency anemia | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
| — | NCT00554814 Comparator | Nov 2007 → Nov 2008 | disorder of iron metabolism and transport | Bledina | Suspended | No outcome recorded |
| — | NCT00459225 Comparator | Apr 2007 → Jun 2013 | anemia | Emory University | Withdrawn | No outcome recorded |
Evidence & citations 28 cited values
Every value below carries the sentence it was read from. 167 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ferrous sulfate | “The purpose of the study was to compare the efficacy of oral iron (ferrous sulfate) plus erythropoietin to Iron Sucrose plus erythropoietin for managing anemia patients with...” NCT00236964 ↗90“In the standard iron-folic acid supplementation group, participants diagnosed with iron deficiency anemia will receive ferrous sulfate tablets providing 60 mg of elemental iron...” NCT07661602 ↗ “Drug: FerroGrad by Abbott Dosage: one capsule three times /day containing150 mg of dried ferrous sulfate capsules (Ferrofol capsules, Eipico, Egypt), with placebo sachets.” NCT03202615 ↗ “oral ferrous iron preparations (ferrous sulfate), each providing 160 mg elemental iron once daily, administered on an empty stomatch with 200 mg vitamin c for 3 months.” NCT07366502 ↗ “either hydroxide polymaltose \[Ferrum Haussman®\] or ferrous sulfate \[Ferro Gradumet®\]” NCT07708025 ↗ “Oral iron supplementation with ferrous sulfate has been considered the standard of care” NCT03957057 ↗ “Ca. 200-300 mg of ferrous sulfate will be administered orally every day for 3 months.” NCT05060731 ↗ “Group II received ferrous sulfate (element Fe 1-2 mg/kg•day) once a day for 6 months” NCT01355263 ↗ “Participants given tablet Ferrous sulfate, 325 mg orally three times a day.” NCT07340450 ↗ “40 doses of 30 mg of ferrous sulfate during a 10-month intervention period” NCT00992823 ↗ “Oral ferrous sulfate 325 mg twice daily was administered for 12 months.” PMID 36406817 ↗ Nov 2022 “or ferrous sulfate (FeSO(4)) 325 mg orally thrice daily for 6 weeks.” PMID 17666600 ↗ Aug 2007 “325 mg ferrous sulfate orally three times daily x 8 weeks” NCT00223977 ↗ “Ferrous Sulfate, Venofer, Ferrlecit, Infed, Dexferrum” NCT00704353 ↗ “standard care (oral ferrous sulfate (N=40).” NCT05340465 ↗ “Iron (Ferrous Sulfate) 34 mg” NCT02558725 ↗ “ferrous sulfate” NCT04975074 ↗ “Ferrous sulfate” NCT00223938 ↗ |
| Known as | Chinese medicine filling iron agent | “Chinese medicine filling iron agent” NCT04975074 ↗ |
| Known as | Dried Ferrous Sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05299411 ↗ |
| Known as | Eisen-II-Sulfat | “Oral iron supplementation with Eisen-II-Sulfat (Tardyferon ®) Every second day 2 x 80 mg Tardyferon® for a duration of 12 weeks.” NCT06238895 ↗ |
| Known as | FeFum | “a complementary food (CF) fortified with sodium iron EDTA (NaFeEDTA) plus either ferrous fumarate (FeFum) or ferric pyrophosphate (FePP)” PMID 28708072 ↗ Jul 2017 |
| Known as | Fer-In-Sol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02905981 ↗ |
| Known as | Ferli-6 | “3 ferrous fumarate tablets (Ferli-6®) everyday” NCT00746551 ↗ |
| Known as | Feroba-YOU | “Ferrous sulfate(Feroba-YOU) per oral” NCT03229954 ↗ |
| Known as | Ferro Gradumet | “either hydroxide polymaltose \[Ferrum Haussman®\] or ferrous sulfate \[Ferro Gradumet®\]” NCT07708025 ↗ |
| Known as | FerroGrad | “Drug: FerroGrad by Abbott Dosage: one capsule three times /day containing150 mg of dried ferrous sulfate capsules (Ferrofol capsules, Eipico, Egypt), with placebo sachets.” NCT03202615 ↗ |
| Known as | Ferrous fumarate | “LNG/ethinyl estradiol (EE)/ferrous fumarate combined oral contraceptive (COC) regimen” NCT05233956 ↗32“Calcium Carbonate 150 mg/day Ferrous Fumarate 27 mg/day Zinc Oxide 25 mg/day” NCT02620345 ↗ “patients are randomized to 300 mg of ferrous fumarate or placebo for 4 weeks” NCT00152841 ↗ “3 ferrous fumarate tablets (Ferli-6®) everyday” NCT00746551 ↗ “ferrous fumarate or ferrous gluconate” NCT01414075 ↗ “Ferrous fumarate” NCT01155375 ↗ |
| Known as | ferrous succinate | “Other drugs to treat anemia include: Recombinant human eythropoietin (RH-EPO), iron agents (ferrous succinate, polysaccharide iron complex, iron sucrose, etc.)” NCT05691257 ↗7“If necessary, oral ferrous succinate, vitamins B12 and folic acid will be administered.” NCT03010579 ↗ “ferrous succinate” NCT04975074 ↗ |
| Known as | ferrous sulphate | “Directly Observed Home based Daily Iron( ferrous sulphate) therapy (DOHBIT) will be provided to the anemic women by the local village volunteers.” NCT01129843 ↗31“200 mg of dried ferrous sulphate tablet once daily for 30 days on empty stomach but may be taken with meals to avoid stomach upset” NCT03759353 ↗ “after single oral administration of 2 tablets of L0008 80 mg (as ferrous sulphate) in women with iron deficiency anaemia.” NCT01757119 ↗ “The pregnant women randomized to the control arm (FS) will be given one 200mg tablet of ferrous sulphate” NCT04976179 ↗ “oral ferrous sulphate 325 mg thrice daily for a total of 195 mg elemental iron daily for 56 days” PMID 20929915 ↗ Oct 2010 “Routine group: 60 mg per day of ferrous sulphate (combination with folic acid) daily.” NCT00488579 ↗ “either oral Ferrous Sulphate (FS) 200 mg three times a day or placebo” PMID 36578916 ↗ Nov 2022 “ferrous sulphate oral in the form of syrup” NCT06176430 ↗ “oral iron(ferrous Sulphate)” NCT07110935 ↗ |
| Known as | Ferrous sulphate tablets | “Drug: Ferrous sulphate tablets” NCT00919230 ↗ |
| Known as | Ferrum Haussman | “either hydroxide polymaltose \[Ferrum Haussman®\] or ferrous sulfate \[Ferro Gradumet®\]” NCT07708025 ↗ |
| Known as | FeSO(4) | “A combination dosage of prebiotic (Inulin or GOS) and Iron Fortificant (FeSO4 or NaFeEDTA) will be given to the study subjects.” NCT03894449 ↗1“ferrous sulfate (FeSO(4)) 325 mg orally thrice daily for 6 weeks.” PMID 17666600 ↗ Aug 2007 |
| Known as | Hema-caps | “75 pregnant women will recommended to take ferrous fumarate e.g. Hema-caps (ferrous fumarate 350 mg with elemental iron 115mg) prepared by another egyptian pharmaceutical...” NCT03830034 ↗ |
| Known as | hydroxide polymaltose | “either hydroxide polymaltose \[Ferrum Haussman®\] or ferrous sulfate \[Ferro Gradumet®\]” NCT07708025 ↗ |
| Known as | ionic iron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01865175 ↗ |
| Known as | Iron | “Iron (ferrous sulfate)” NCT00459225 ↗ |
| Known as | L0008 | “after single oral administration of 2 tablets of L0008 80 mg (as ferrous sulphate)” NCT01757119 ↗ |
| Known as | Oral Iron | “Oral Iron (Ferrous sulphate)” NCT07659184 ↗ |
| Known as | polyferose | “polyferose” NCT04975074 ↗ |
| Known as | Tardyfer | “ferrous sulphate (Tardyfer®) 160 mg daily for 6 weeks” NCT03957057 ↗ |
| Known as | Tardyferon | “Oral iron supplementation with Eisen-II-Sulfat (Tardyferon ®) Every second day 2 x 80 mg Tardyferon® for a duration of 12 weeks.” NCT06238895 ↗ |
| Known as | Upsher-Smith ferrous sulfate 325 mg tablets NDC# 00245-0108-11 | “Upsher-Smith ferrous sulfate 325 mg tablets NDC# 00245-0108-11” NCT01438372 ↗ |
| Modality | Diagnostic / imaging agent | “For assessment of incorporation of iron into erythrocytes, participants will be administered ferrous sulfate containing a stable isotope of iron (57Fe) orally” NCT03457701 ↗ |
| Route | Oral | “Oral Iron” NCT00223938 ↗ |